Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Lymphoma Myeloma Leuk ; 21(1): e66-e75, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32943371

RESUMO

Histiocytic disorders are an exceptionally rare group of diseases with diverse manifestations and a paucity of approved treatments, thereby leading to various challenges in their diagnosis and management. With the discovery of novel molecular targets and the incorporation of targeted agents in the management of various adult histiocytic disorders, their management has become increasingly complex. In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created this document based on existing literature and expert opinion.


Assuntos
Doença de Erdheim-Chester/tratamento farmacológico , Histiocitose de Células de Langerhans/tratamento farmacológico , Histiocitose Sinusal/tratamento farmacológico , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Adulto , Quimioterapia Combinada , Doença de Erdheim-Chester/diagnóstico , Histiocitose de Células de Langerhans/diagnóstico , Histiocitose Sinusal/diagnóstico , Humanos , Linfo-Histiocitose Hemofagocítica/diagnóstico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...